The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?

Benot-Dominguez, Reyes; Cimini, Annamaria; Barone, Daniela; Giordano, Antonio; Pentimalli, Francesca

Benot-Dominguez, Reyes; Cimini, Annamaria; Barone, Daniela; Giordano, Antonio; Pentimalli, Francesca.

Afiliación

Benot-Dominguez R; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.
Cimini A; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Barone D; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, 80131 Napoli, Italy.
Giordano A; Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.
Pentimalli F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.

Cancers (Basel) ; 14(11)2022 May 30.

Article en En | MEDLINE | ID: mdl-35681689

Palabras clave

CDK inhibitors (CDKIs); CDK4/6; RB1; breast cancer; cell-cycle inhibitors; diet-induced obesity (DIO); ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google